HomeNAMS • NASDAQ
add
NewAmsterdam Pharma Company NV
Previous close
$17.62
Day range
$17.42 - $18.31
Year range
$5.63 - $26.29
Market cap
1.64B USD
Avg Volume
249.81K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 2.28M | 32.73% |
Operating expense | 54.85M | 24.11% |
Net income | -39.01M | -1.87% |
Net profit margin | -1.71K | 23.25% |
Earnings per share | -0.38 | — |
EBITDA | -52.56M | -23.75% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 430.71M | 2.88% |
Total assets | 446.69M | -13.15% |
Total liabilities | 59.25M | 11.14% |
Total equity | 387.44M | — |
Shares outstanding | 90.02M | — |
Price to book | 4.10 | — |
Return on assets | -28.11% | — |
Return on capital | -32.87% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -39.01M | -1.87% |
Cash from operations | -53.98M | -84.20% |
Cash from investing | -209.00K | -4,080.00% |
Cash from financing | 4.66M | -26.46% |
Net change in cash | -50.44M | -104.99% |
Free cash flow | -47.34M | — |
About
Founded
2019
Website
Employees
57